Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275460
Max Phase: Preclinical
Molecular Formula: C42H41NO21
Molecular Weight: 895.78
Associated Items:
ID: ALA5275460
Max Phase: Preclinical
Molecular Formula: C42H41NO21
Molecular Weight: 895.78
Associated Items:
Canonical SMILES: COC(=O)[C@H](C)NC(=O)COc1c(OC(C)=O)cc(C(=O)O[C@@H]2Cc3c(OC(C)=O)cc(OC(C)=O)cc3O[C@@H]2c2cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c2)cc1OC(C)=O
Standard InChI: InChI=1S/C42H41NO21/c1-18(41(52)54-9)43-37(51)17-55-39-32(58-21(4)46)12-27(13-33(39)59-22(5)47)42(53)64-36-16-29-30(57-20(3)45)14-28(56-19(2)44)15-31(29)63-38(36)26-10-34(60-23(6)48)40(62-25(8)50)35(11-26)61-24(7)49/h10-15,18,36,38H,16-17H2,1-9H3,(H,43,51)/t18-,36+,38+/m0/s1
Standard InChI Key: LWUZXTFPYHTLNV-DYLFEXJZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 895.78 | Molecular Weight (Monoisotopic): 895.2171 | AlogP: 3.12 | #Rotatable Bonds: 15 |
Polar Surface Area: 284.26 | Molecular Species: NEUTRAL | HBA: 21 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 22 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.13 | CX Basic pKa: | CX LogP: 1.69 | CX LogD: 1.69 |
Aromatic Rings: 3 | Heavy Atoms: 64 | QED Weighted: 0.17 | Np Likeness Score: 0.51 |
1. Lee H, Jeong JH, Lee T, Chong Y, Choo H, Lee S.. (2023) Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway., 90 [PMID:37182610] [10.1016/j.bmcl.2023.129325] |
Source(1):